Browse > Article
http://dx.doi.org/10.4014/jmb.1804.04042

Design, Synthesis and Evaluation of Pentacyclic Triterpenoids Similar to Glycyrrhetinic Acid Via Combination of Chemical and Microbial Modification as Glycogen Phosphorylases Inhibitor  

Zhu, Yuyao (Nanjing Research Institute for Comprehensive Utilization of Wild Plants)
Zhang, Jian (Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University)
Huang, Xiaode (Nanjing Research Institute for Comprehensive Utilization of Wild Plants)
Chen, Bin (Nanjing Research Institute for Comprehensive Utilization of Wild Plants)
Qian, Hua (Nanjing Research Institute for Comprehensive Utilization of Wild Plants)
Zhao, Botao (Nanjing Research Institute for Comprehensive Utilization of Wild Plants)
Publication Information
Journal of Microbiology and Biotechnology / v.28, no.11, 2018 , pp. 1876-1882 More about this Journal
Abstract
A series of pentacyclic triterpenoids similar to glycyrrhetinic acid were designed and synthesized via the combination of chemical modification and microbial catalysis. All products were screened for the glycogen phosphorylases inhibitory activities in vitro. Within this series of derivatives, compound 5 displayed good inhibitory activities with $IC_{50}$ value of $27.7{\mu}M$, which is better than that of the other derivatives and glycyrrhetinic acid. Structure-activity relationship (SAR) analysis of these inhibitors was also discussed.
Keywords
Biocatalysis; glycyrrhetinic acid; oleanolic acid; Streptomyces griseus ATCC 13273; Aspergillus ochraceus CICC 40330;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Andres P, Francisco R, Andres G, Antonio M. 2009. Microbial transformation of triterpenoids. Mini-Rev. Org. Chem. 6: 307-320.   DOI
2 Qian LW, Zhang J, Liu JH, Yu BY. 2009. Direct microbialcatalyzed asymmetric ${\alpha}$-hydroxylation of betulonic acid by Nocardia sp. NRRL 5646. Tetrahedron Lett. 50: 2193-2195.   DOI
3 Zhu YY, Qian LW, Zhang J, Liu JH, Yu BY. 2011. New approaches to the structural modification of olean-type pentacylic triterpenes via microbial oxidation and glycosylation. Tetrahedron 67: 4206-4211.   DOI
4 Oikonomakos NG. 2002. Glycogen phosphorylase as a molecular target for type-2 diabetes therapy. Curr. Protein Pept. Sci. 3: 561-586.   DOI
5 Wen X, Su H, Liu J, Wu G., Zhang L, Wu X, Ni P. 2005. Pentacyclic triterpenes. Part 1: The first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases. Bioorg. Med. Chem. Lett. 15: 4944-4948.   DOI
6 Wen X, Sun H, Liu J, Cheng K, Zhang P, and Zhang L. 2008. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and x-ray crystallographic studies. J. Med. Chem. 51: 3540-3554.   DOI
7 Jacques M. 1987. Synthesis of unsaturated carbonyl compounds via a chromium-mediated allylic oxidation by 70% tertbutylhydroperoxide. Tetrahedron Lett. 28: 4665-4668.   DOI
8 Werner S., Nebojsa S., Robert W. 2003. Spectral assignments and reference data. Magn. Reson. Chem. 41: 636-638.   DOI
9 Li JF, Chen SJ, Zhao Y, Li JX. 2009. Glycoside modification of oleanolic acid derivatives as a novel class of antiosteoclast formation agents. Carbohydr. Res. 344: 599-605.   DOI
10 Yuko F, Takeshi Y, Shun-ich W, Kuniyoshi S, Shunyo M, Reiko T. Lupane. 2006. Oleanane Triterpenoids from the Cones of Liquidamber styraciflua. J. Nat. Prod. 69: 142-144.   DOI
11 Robert AH, Joseph D. 2013. C. Triterpenoids. Nat. Prod. Rep. 30: 1028-1065.   DOI
12 Honda T, Rounds BV, Bore L, Finlay HJ, Favaloro Jr FG, Suh N, et al. 2000. Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages. J. Med. Chem. 43: 4233-4246   DOI
13 Martinez A, Garcia-Granados A, Rivas F, Garcia-Granados A. 2009. Microbial transformation of triterpenoids. Mini-Rev. Org. Chem. 6: 307-320.   DOI
14 Mauro S, Cristina F, Decio A, Antonio T. 2003. Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria. Biochem. Pharmacol. 66: 2375-2379.   DOI
15 Armanini D, Fiore C, Mattarello MJ, Bielenberg J. Palermo M. 2002. History of the endocrine effects of licorice. Exp. Clin. Endocrinol. Diabetes. 110: 257-261.   DOI
16 Shibata S. 2000. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi. 120: 849-862.   DOI
17 Rene C, Stefan S, Ralph K, Dieter S. 2010. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid. Eur. J. Med. Chem. 45: 5718-5723.   DOI
18 Matsui S, Matsumoto H, Sonoda Y, Ando K, Aizu-Yokota E, Sato T, et al. 2004. Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line. Int. Immunopharmacol. 15: 1633-1644.
19 Wu X, Zhang L, Gurley E, S tuder E, Shang J , Wang T, et al. 2008. Prevention of free fatty acid-induced hepatic lipotoxicity by 18${\beta}$-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology 47: 1905-1915.   DOI
20 Anthony PG, Nicholas JT, Elaine O'Reilly. 2014. Chiral amine synthesis using w-Transaminases: an amine donor that displaces equilibria and enables high-throughput screening. Angew. Chem. Int. Ed. 53: 10714-10717.   DOI
21 Ramesh NP. 2001. Enzymatic synthesis of chiral intermediates for drug development. Adv. Synth. Catal. 343: 6-7.
22 David JP, John MW. 2006. Biocatalysis for pharmaceutical intermediates: the future is now. Trends Biotechnol. 25: 66-73.